Skip to main content
Veterinary Medicines

INGELVAC MYCOFLEX SUSPENSION FOR INJECTION FOR PIGS

Authorised
  • Mycoplasma hyopneumoniae, strain J, Inactivated

Product identification

Medicine name:
INGELVAC MYCOFLEX SUSPENSION FOR INJECTION FOR PIGS
Ingelvac Mycoflex Suspensie voor injectie
Ingelvac Mycoflex Suspension injectable
Ingelvac Mycoflex Injektionssuspension
Active substance:
  • Mycoplasma hyopneumoniae, strain J, Inactivated
Target species:
  • Pigs (for fattening)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Mycoplasma hyopneumoniae, strain J, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pigs (for fattening)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB13
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Cardboard box with 1 high density polyethylene bottle of 50 ml (50 doses in 120 ml bottles) vaccine
  • Cardboard box with 1 high density polyethylene bottle of 100 ml (100 doses in 250 ml bottles) vaccine
  • Cardboard box with 1 high density polyethylene bottle of 250 ml (250 doses in 500 ml bottles) vaccine
  • Cardboard box with 12 high density polyethylene bottles of 10 ml (10 doses in 30 ml bottles) vaccine
  • Cardboard box with 12 high density polyethylene bottles of 50 ml (50 doses in 120 ml bottles) vaccine
  • Cardboard box with 12 high density polyethylene bottles of 100 ml (100 doses in 250 ml bottles) vaccine
  • Cardboard box with 12 high density polyethylene bottles of 250 ml (10 doses in 500 ml bottles) vaccine
  • Cardboard box with 1 density polyethylene TwistPak bottle of 10 ml (10 doses in 30 ml) vaccine
  • Cardboard box with 1 density polyethylene TwistPak bottle of 50 ml (50 doses in 50 ml) vaccine
  • Cardboard box with 1 density polyethylene TwistPak bottle of 100 ml (100 doses in 100 ml) vaccine
  • Cardboard box with 1 density polyethylene TwistPak bottle of 250 ml (250 doses in 250 ml) vaccine
  • Cardboard box with 12 high density polyethylene TwistPak bottles of 10 ml (10 doses in 30 ml bottles) vaccine
  • Cardboard box with 12 high density polyethylene TwistPak bottles 50 ml (50 doses in 50 ml bottles) vaccine
  • Cardboard box with12 high density polyethylene TwistPak bottles of 100 ml (100 doses in 100 ml bottles) vaccine
  • Cardboard box with 12 high density polyethylene TwistPak bottles of 250 ml (250 doses in 250 ml bottles) vaccine
  • Cardboard box with 1 high density polyethylene bottle of 10 ml (10 doses in 30 ml bottles) vaccine

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Vetmedica GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V340085
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0203/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
German (PDF)
Published on: 22/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."